Your browser doesn't support javascript.
loading
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma.
Logue, Jennifer M; Zucchetti, Elisa; Bachmeier, Christina A; Krivenko, Gabriel S; Larson, Victoria; Ninh, Daniel; Grillo, Giovanni; Cao, Biwei; Kim, Jongphil; Chavez, Julio C; Baluch, Aliyah; Khimani, Farhad; Lazaryan, Aleksandr; Nishihori, Taiga; Liu, Hien D; Pinilla-Ibarz, Javier; Shah, Bijal D; Faramand, Rawan; Coghill, Anna E; Davila, Marco L; Dholaria, Bhagirathbhai R; Jain, Michael D; Locke, Frederick L.
Afiliação
  • Logue JM; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Zucchetti E; Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Bachmeier CA; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Krivenko GS; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Larson V; Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Ninh D; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Grillo G; Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Cao B; Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Kim J; Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Chavez JC; Dept. of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Baluch A; Dept. of Infectious Diseases, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Khimani F; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Lazaryan A; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Nishihori T; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Liu HD; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Pinilla-Ibarz J; Dept of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Shah BD; Dept of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Faramand R; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Coghill AE; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Davila ML; Dept. of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Dholaria BR; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Jain MD; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
  • Locke FL; Dept. of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, USA.
Haematologica ; 106(4): 978-986, 2021 04 01.
Article em En | MEDLINE | ID: mdl-32327504
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Reconstituição Imune Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Reconstituição Imune Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article